We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Epilepsy Drug Linked To Blood Disorder: FDA

Law360 (February 23, 2009, 12:00 AM EST) -- The epilepsy drug zonisamide — marketed under the brand name Zonegran by Eisai Co. Ltd. and sold in generic form by Teva Pharmaceutical Industries Ltd., Mylan Inc., Novartis AG’s Sandoz unit and Watson Pharmaceuticals Inc. — has come under fire by federal health regulators, who warned Monday the medication can cause a serious blood disorder known as metabolic acidosis in some patients.

The U.S. Food and Drug Administration said it had made the determination following a review of updated clinical data related to zonisamide, which is...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.